Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, and Medical Imaging Techniques and Applications.
Polygenic pathways shape white matter vulnerability to Alzheimer’s disease-related pathophysiological changes
Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests
Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology
Quantification supports amyloid-PET visual assessment of challenging cases: results from the AMYPAD-DPMS study
Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients
Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline
Eigenvector centrality dynamics are related to Alzheimer’s disease pathological changes in non-demented individuals
Differential associations between regional amyloid PET and Alzheimer’s disease polygenic risk scores
Comparing parametric methods for longitudinal measurement of β‐amyloid pathology with PET in elderly individuals
Quantification of amyloid PET for future clinical use: a state-of-the-art review
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
White matter microstructure disruption in early stage amyloid pathology
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity